Early postoperative serum aspartate aminotransferase for prediction of post-hepatectomy liver failure

Watoo Vassanasiri1, Narongsak Rungsakulkij2, Wikran Suragul1

  • 1Department of Surgery, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, 270 Praram VI Road, Ratchathewi, Bangkok, 10400, Thailand.

Insights

Early detection of post-hepatectomy liver failure (PHLF) is crucial. Elevated serum AST on postoperative day 1 can predict PHLF, enabling earlier intervention for at-risk patients.

Area of Science:

  • Hepatobiliary Surgery
  • Surgical Complications
  • Liver Function Tests

Background:

  • Post-hepatectomy liver failure (PHLF) is a significant complication following liver resection.
  • Current diagnostic criteria (ISGLS) rely on data from postoperative day 5, potentially delaying critical interventions.

Purpose of the Study:

  • To investigate the association between early postoperative (POD1) serum aminotransferase levels and the development of PHLF.
  • To identify early predictive markers for PHLF risk.

Main Methods:

  • Retrospective analysis of 890 patients undergoing hepatectomy between 2008-2019.
  • Comparison of preoperative, intraoperative, and early postoperative laboratory data (AST, ALT, bilirubin, INR) between PHLF and non-PHLF groups.

Main Results:

  • 3.4% of patients developed PHLF.
  • POD1 cut-off values of AST > 260 U/L and ALT > 270 U/L predicted PHLF.
  • Independent predictors of PHLF included POD1 AST > 260 U/L, ICG-R15, major hepatectomy, blood loss, and INR.

Conclusions:

  • Elevated serum AST on POD1 serves as an early warning sign for PHLF risk.
  • Early identification allows for prompt initiation of active management and vigilant monitoring.
  • This approach can improve patient outcomes by enabling earlier intervention.
Abstract